The Rise in Appendiceal Cancer Incidence: 2000–2009
- 704 Downloads
Appendiceal cancer is a rare and potentially aggressive malignancy. The objectives of this study were to characterize secular demographic patterns of disease and to determine survival by using a population-based data source.
Using the Surveillance, Epidemiology, and End Results database, we conducted a retrospective cohort analysis of patients treated from 2000–2009.
We identified 4765 patients with appendiceal cancer. The incidence of appendiceal cancer increased by 54 % from 2000 (0.63 per 100,000) to 2009 (0.97 per 100,000 population). Incidence rates increased across all tumor types, stages, age groups, and gender. The most common malignancies were mucinous adenocarcinoma (38 %), followed by carcinoids (28 %), adenocarcinoma-not otherwise specified (NOS) (27 %), and signet ring cell adenocarcinoma (7 %). Larger tumor size and older patient age were significantly associated with higher relative odds of distant disease at diagnosis (P < 0.0001). Patient and demographic characteristics were significantly associated with higher relative hazard of death (P < 0.0001).
Although appendiceal cancer is rare, the incidence increased significantly in the USA from 2000 to 2009. The cause of this trend is not obvious. We did not observe increases differentially associated with stage, histology, or demographic characteristics. Further investigation is needed to examine factors underlying this increase.
KeywordsAppendiceal Cancer SEER program Survival
Funding for this study
This research was generously supported by the Betti Boers Maloney Appendiceal Cancer Research Fund at the University of Minnesota Foundation
Conflicts of interest
No financial disclosures/conflicts of interest.
- 6.Surveillance. Epidemiology, and End Results. Available at: http://seer.cancer.gov. Accessed April 10, 2013.
- 8.Phillips, K. A., Liang, S. Y., Ladabaum, U., Haas, J., Kerlikowske, K., Lieberman, D., … & Van Bebber, S. L. (2007). Trends in colonoscopy for colorectal cancer screening. Medical care, 45(2), 160–167.Google Scholar
- 10.Levine, E. A., Blazer III, D. G., Kim, M. K., Shen, P., Stewart IV, J. H., Guy, C., & Hsu, D. S. (2012). Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. Journal of the American College of Surgeons, 214(4), 599–606.CrossRefPubMedCentralPubMedGoogle Scholar
- 11.American Cancer Society. Available at: http://www.cancer.org/ Accessed May 5, 2014.
- 16.Andreyev, H. J. N., Norman, A. R., Oates, J., & Cunningham, D. (1998). Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. European Journal of Cancer,34(4), 503–509.Google Scholar
- 17.Gouma, D. J., Van Geenen, R. C., van Gulik, T. M., de Haan, R. J., de Wit, L. T., Busch, O. R., & Obertop, H. (2000). Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume.Annals of surgery, 232(6), 786.CrossRefPubMedCentralPubMedGoogle Scholar
- 18.Gordon, T. A., Bowman, H. M., Bass, E. B., Lillemoe, K. D., Yeo, C. J., Heitmiller, R. F., … & Cameron, J. L. (1999). Complex gastrointestinal surgery: impact of provider experience on clinical and economic outcomes. Journal of the American College of Surgeons, 189(1), 46–56.Google Scholar